Header
Header
Article

Regulatory T lymphocytes as a therapy for ischemic stroke



Review


doi: 10.1007/s00281-022-00975-z.


Online ahead of print.

Affiliations

Item in Clipboard

Review

Miao Wang et al.


Semin Immunopathol.


.

Abstract

Unrestrained excessive inflammatory responses exacerbate ischemic brain injury and impede post-stroke brain recovery. CD4+CD25+Foxp3+ regulatory T (Treg) cells play important immunosuppressive roles to curtail inflammatory responses and regain immune homeostasis after stroke. Accumulating evidence confirms that Treg cells are neuroprotective at the acute stage after stroke and promote brain repair at the chronic phases. The beneficial effects of Treg cells are mediated by diverse mechanisms involving cell-cell interactions and soluble factor release. Multiple types of cells, including both immune cells and non-immune CNS cells, have been identified to be cellular targets of Treg cells. In this review, we summarize recent findings regarding the function of Treg cells in ischemic stroke and the underlying cellular and molecular mechanisms. The protective and reparative properties of Treg cells endorse them as good candidates for immune therapy. Strategies that boost the numbers and functions of Treg cells have been actively developing in the fields of transplantation and autoimmune diseases. We discuss the approaches for Treg cell expansion that have been tested in stroke models. The application of these approaches to stroke patients may bring new hope for stroke treatments.


Keywords:

Brain repair; Immunoregulation; Neuroprotection; Regulatory T cell.

References

    1. Nishizuka Y, Sakakura T (1969) Thymus and reproduction: sex-linked dysgenesia of the gonad after neonatal thymectomy in mice. Science 166:753–755



      PubMed



      DOI

    1. Kojima A, Prehn RT (1981) Genetic susceptibility to post-thymectomy autoimmune diseases in mice. Immunogenetics 14:15–27



      PubMed



      DOI

    1. Hori S, Nomura T, Sakaguchi S (2003) Control of regulatory T cell development by the transcription factor Foxp3. Science 299:1057–1061



      PubMed



      DOI

    1. Munoz-Rojas AR, Mathis D (2021) Tissue regulatory T cells: regulatory chameleons. Nat Rev Immunol 21:597–611



      PubMed



      PMC



      DOI

    1. Anrather J, Iadecola C (2016) Inflammation and stroke: an overview. Neurotherapeutics 13:661–670



      PubMed



      PMC



      DOI



Source link

Back to top button